Reading Time: 4 minutesAlthough ALS is a neurodegenerative disease, researchers are increasingly also interested in events happening outside the brain and spinal cord, in particular whether changes in
Category: Treatments
Reading Time: 5 minutesThis blog is part of the ‘Highlights from Perth’ collection of articles, where you can read about the content of some of the talks and
Reading Time: 4 minutesThis blog is part of the ‘Highlights from Perth’ collection of articles, where you can read about the content of some of the talks and
Reading Time: 3 minutesTUDCA-ALS is a European Consortium (funded by the European Commission under the Horizon 2020 grant) involving top researchers from seven countries across Europe (see Figure
Reading Time: 5 minutesThere are literally thousands of websites on the internet that make claims about amazing alternative or off-label treatments (AOTs) and even cures for MND but
Reading Time: 2 minutesThis article was written by Dr Keith Mayl and Dr Ahmad Al Khleifat of King’s College London. Researchers at King’s College Hospital, led by Professor
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Models of MND Research we fund Treatments
How animals are helping to improve our understanding of MND
Reading Time: 6 minutes‘From antibiotics and insulin to blood transfusions and treatments for cancer or HIV, virtually every medical achievement in the past century has depended directly or
Reading Time: 3 minutesA recent press release by the pharmaceutical company Biogen reported preliminary results from an ongoing clinical trial investigating a form of precision therapy in people
Reading Time: 10 minutes“The annals of ALS clinical trials is strewn with failed studies. Only two out of more than 70 clinical trials have been positive, and even
Reading Time: 7 minutesIs it possible that a drug that treats congestive heart failure could improve respiration in people with MND? Or that a drug used to treat